Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Metoclopramide 15mg modified-release capsules
0406000P0AAAJAJ
|
Metoclopramide hydrochloride | Metoclopramide hydrochloride | Central Nervous System | No data available |
|
Metoclopramide 15mg modified-release tablets
0406000P0AAAHAH
|
Metoclopramide hydrochloride | Metoclopramide hydrochloride | Central Nervous System | No data available |
|
Mianserin 10mg/5ml oral liquid
0403010T0AAAFAF
|
Mianserin hydrochloride | Mianserin hydrochloride | Central Nervous System | No data available |
|
Mianserin 20mg tablets
0403010T0AAABAB
|
Mianserin hydrochloride | Mianserin hydrochloride | Central Nervous System | No data available |
|
Mianserin 20mg/5ml oral liquid
0403010T0AAADAD
|
Mianserin hydrochloride | Mianserin hydrochloride | Central Nervous System | No data available |
|
Mianserin 30mg/5ml oral liquid
0403010T0AAAEAE
|
Mianserin hydrochloride | Mianserin hydrochloride | Central Nervous System | No data available |
|
Midazolam 11mg/5ml oral liquid
0408020V0AAAMAM
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 15mg tablets
0408020V0AAABAB
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 2.5mg/0.25ml oromucosal soln pf oral syringes
0408020W0AAAGAG
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | No data available |
|
Midazolam 2.5mg/5ml oral liquid
0408020V0AAAGAG
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 20mg/5ml oral liquid
0408020V0AAAJAJ
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 2mg/ml oral solution sugar free
0408020W0AAAHAH
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | No data available |
|
Midazolam 40mg/5ml oral liquid
0408020V0AAAKAK
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 6.25mg/5ml oral liquid
0408020V0AAAIAI
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 7.5mg tablets
0408020V0AAACAC
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 7.5mg/0.75ml oromucosal soln pf oral syringes
0408020V0AAAUAU
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Migarid-10 tablets
0406000E0BDAAAB
|
Migarid-10 | Flunarizine dihydrochloride | Central Nervous System | No data available |
|
Migraine Relief 8mg/500mg capsules
0407010F0BCABAB
|
Boots (Co-codamol) | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Migraleve Ultra 50mg tablets
0407041T0BCAAAF
|
Migraleve Ultra | Sumatriptan succinate | Central Nervous System | No data available |
|
Milnacipran 50mg capsules
040304000AAABAB
|
Generic compound preparation BNF 0403040 | Other antidepressant preparations | Central Nervous System | No data available |
|
Miradol 500mg tablets
0407010H0BYAAAM
|
Miradol | Paracetamol | Central Nervous System | No data available |
|
Mirtazapine 15mg orodispersible tablets sugar free
0403040X0AAAQAQ
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 15mg/5ml oral solution
0403040X0AAASAS
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 2mg capsules
0403040X0AAAIAI
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
|
Mirtazapine 30mg/5ml oral liquid
0403040X0AAABAB
|
Mirtazapine | Mirtazapine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.